Why did MANGALAM.BO stock fall in pre-market trade today?

MANGALAM.BO stock fell due to negative sentiment, above-average relative volume of **3.38**, and ongoing loss-making results (EPS **-12.51**). Traders reacted to weak fundamentals and inventory strain, pushing the price down to **INR 31.92** in pre-market.

What are the key support and resistance levels for MANGALAM.BO stock?

Key support is the 52-week low at **INR 22.70** and a near-term cluster around **INR 28.00**. Main resistance is the 50-day average at **INR 39.66** and psychological resistance near **INR 40.00**.

What does Meyka AI forecast imply for MANGALAM.BO stock?

Meyka AI's model projects **INR 40.92** for one year, implying **+28.20%** upside versus **INR 31.92** now. The monthly model shows **INR 18.58**, implying near-term downside. Forecasts are model-based and not guarantees.

Is MANGALAM.BO stock a buy based on valuation?

Valuation looks cheap with PB **0.46** and P/S **0.22**, but negative earnings and liquidity metrics raise risk. Meyka AI assigns a **C+** grade and suggests a HOLD until margins and cash flow improve.

IN Stocks

Down 9.27%: MANGALAM.BO Mangalam Drugs BSE 31.92 pre-mkt Jan 2026, watch 22.70

ByHuzaifa Zahoor January 9, 2026January 9, 2026

MANGALAM.BO stock fell 9.27% to INR 31.92 in pre-market trade on 09 Jan 2026, making it one of today’s top losers on the BSE. The move follows heavy relative volume of 3.38 versus a five-week average and pushes the share nearer to its 52-week low of INR 22.70. Investors should note negative trailing EPS of -12.51 and a negative PE of -2.95, which underline profit pressure. This piece outlines valuation, technical levels, a Meyka AI grade, and price forecasts to frame near-term trade and risk.